Dr Maria Atta
Primary medical qualifications:
MD
Foreign languages:
Greek
GMC number:
6159780
Specialities:
Background
Dr Maria Atta has been working as a consultant haematologist at the Hammersmith Hospital, Imperial College Healthcare NHS Trust, since 2017, with clinical interest in multiple myeloma and other related plasma cell disorders. She graduated from Aristotle University Medical School, Greece in 2006 and completed her medical training in the UK and her haematology training in Athens, Greece. She worked as a Clinical Fellow at Hammersmith Hospital between 2016-2017, before joining as a haematology consultant in 2017. She is a member of the UK Myeloma Society and the UK Myeloma Research Alliance. She is the chief, primary and co-investigator in several clinical trials on multiple myeloma and a member of the Hugh and Josseline Langmuir Centre for Myeloma Research.
Expertise
Multiple Myeloma, Plasma cell dyscrasias, MGRS, AL Amyloidosis, Bone marrow transplantation
Research & publications
Non-crystalline light chain proximal tubulopathy, a morphologically protean entity.
Kousios A, Blakey S, Moran L, Atta M, Charif R, Duncan N, Smith A, Tam FWK, Levy JB, Chaidos A, Roufosse C. Nephrol Dial Transplant. 2023.
A case of chronic neutrophilic leukemia and multiple myeloma showing the benefits of lenalidomide and cyclophosphamide therapy in treating both conditions.
McVinnie K, Innes A, Nadal-Melsio E, Atta M, Deplano S. Am J Hematol. 2022
Masked crystalline light chain tubulopathy and podocytopathy with focal segmental glomerulosclerosis: a rare MGRS-associated renal lesion.
Kousios A, Mcadoo S, Blakey S, Moran L, Atta M, Tam FWK, Cook HT, Chaidos A,
Roufosse C. Histopathology. 2021
Ethnic Disparities in Waldenström's Macroglobulinaemia in the United Kingdom - Analysis from the Wmuk Rory Morrison Registry.
Aisha S Patel, Jahanzaib Khwaja, Helen McCarthy, Guy Pratt, Jaimal Kothari, Jindriska Lindsay, Roger G Owen, Josephine Crowe, Dima El-Sharkawi, Nilima Parry-Jones, Kirsty Cuthill, Maria Atta, Kim Linton, Agapi Parcharidou, Charalampia Kyriakou, Deborah Turner, Jeffery Smith, Simona Gatto, Nicola Crosbie, Suzanne O Arulogun, Shirley D'Sa. Blood 2021
Over-accessible chromatin links myeloma initiating genetic events to oncogenic transcriptomes and aberrant transcription factor regulatory networks
Alvarez-Benayas, J., Katsarou, A., Trasanidis, N., Chaidos, A., May, P.C., Ponnusamy, K., Xiao, X., Bua, M., Atta, M.L., Roberts, I., Auner, H.W.,Hatjiharissi, E., Papaioannou M, M., Caputo, V.S., Sudbery IM, I.M., & Karadimitris, A. bioRxiv 2020
Identification of occult cerebral microbleeds in adults with immune thrombocytopenia.
Cooper N, Morrison MA, Vladescu C, Hart ACJ, Paul D, Malik A, Young T, Luqmani A, Atta M, Sharp DJ, Bussel JB, Waldman AD. Blood. 2020
Distinct Chromatin Accessibility Changes, Aberrant Transcription Factor Networks
Combined with Novel Oncogenic Enhancers Characterise Myeloma-Initiating
Genetic Events. Trasanidis, N., Alvarez-Benayas, J., Katsarou, A., Chaidos, A., May, P.C.,Ponnusamy, K., Xiao, X., Bua, M., Atta, M.L., Roberts, I., Auner, H.W.,
Hatjiharissi, E., Papaioannou, M., Caputo, V.S., Sudbery, I.M., & Karadimitris, A. Blood 2019
The role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphomas.
Atta M; Papanicolaou N; Tsirigotis P. Transfusion and Apheresis Science. 2011
Procoagulant activities of plasma factor VIIc and factor Xc are positively and independently associated with concentrations of the high-density lipoprotein apolipoprotein, apoA-II.
Atta M; Crook D; Shafique F; Johnston DG; Godsland IF. Thrombosis and Hemostasis .2008